Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A recent study of the direct-acting antiviral regimen included people who contracted hep C within the previous 12 months.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
Experts are not certain what this latest trend signifies for the trajectory of the opioid use disorder epidemic, however.
New cases of all three viruses have declined in the city over the past decade.
Four things you should know to be #HepAware.
A speedy overview of the major scientific findings presented at the International AIDS Conference in Amsterdam (AIDS 2018)
At first, Jerome Adams was reluctant to support needle exchange programs. Now he champions them.
Millions of Americans have chronic hepatitis virus—a leading cause of liver cancer—and don’t even know it.
Even those who did not qualify for a treatment shorter than 12 weeks did well on the regimen in a real-world study.
A look at some science-based facts about HIV that may surprise you as we mark the 35th anniversary of the start of the AIDS epidemic.
Real-world results of eight weeks of the hepatitis C virus treatment Harvoni (ledipasvir/sofosbuvir) are excellent.
The International AIDS Society (IAS) has selected nine researchers to receive four scientific awards.
Researchers found that 11 percent of participants had acquired gonorrhea or chlamydia and that the risk was significantly greater in young, Af...
How Wayne Starks successfully navigated addiction, homelessness and coinfection with HIV and hep C.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.